Synergism between fluconazole and methylene blue-photodynamic therapy against fluconazole-resistant Candida strains

Area of Science:

• Medical Mycology
• Photodynamic Therapy
• Antimicrobial Resistance

Background:

• Photodynamic therapy (PDT) is an effective antifungal treatment.
• PDT can be used alongside conventional antifungal agents to improve efficacy and reduce side effects.
• Resistant fungal infections pose a significant public health challenge.

Purpose of the Study:

• To evaluate the combined effect of methylene blue-based PDT (MB-PDT) and fluconazole against resistant Candida species.
• To determine if MB-PDT and fluconazole exhibit synergistic activity.
• To assess the potential of this combination therapy for enhanced microbial control.

Main Methods:

• Candida albicans, Candida glabrata, and Candida krusei were exposed to sub-inhibitory concentrations of MB-PDT.
• The antifungal efficacy of MB-PDT and fluconazole as single agents was compared to their combined application.
• Microbial inhibition was measured to assess treatment effectiveness.

Main Results:

• MB-PDT combined with fluconazole demonstrated greater inhibition of Candida albicans and Candida glabrata compared to either treatment alone.
• The combination therapy showed enhanced efficacy against the tested resistant yeast strains.
• A synergistic interaction between MB-PDT and fluconazole was observed for C. albicans and C. glabrata.

Conclusions:

• The combination of MB-PDT and fluconazole is more effective against resistant Candida albicans and Candida glabrata than individual treatments.
• This synergistic effect suggests a promising coadjutant strategy for managing resistant fungal infections.
• Further research into this combined therapeutic approach is warranted for improved antifungal strategies.